British Journal of Cancer - Table of Contents alert Volume 114 Issue 11

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 114, Issue 11 (1177-1303) Published online 24 May 2016 In this issue Editorial Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Letters to the Editor Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Editorial Top Countering immunotoxin immunogenicity David J Flavell Br J Cancer 2016 114: 1177-1179; 10.1038/bjc.2016.84 Full Text Minireview Top Context-dependent effects of cellular senescence in cancer development Pacome Lecot, Fatouma Alimirah, Pierre-Yves Desprez, Judith Campisi and Christopher Wiley Br J Cancer 2016 114: 1180-1184; advance online publication, May 3, 2016; 10.1038/bjc.2016.115 Abstract | Full Text Clinical Studies Top Vorinostat in combination with capecitabine plus cisplatin as a first-line chemotherapy for patients with metastatic or unresectable gastric cancer: phase II study and biomarker analysis Changhoon Yoo, Min-Hee Ryu, Young-Soon Na, Baek-Yeol Ryoo, Chae-Won Lee and Yoon-Koo Kang Br J Cancer 2016 114: 1185-1190; advance online publication, May 12, 2016; 10.1038/bjc.2016.125 Abstract | Full Text A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia Paula Jiménez Fonseca, Alberto Carmona-Bayonas, Ignacio Matos García, Rosana Marcos, Eduardo Castañón, Maite Antonio, Carme Font, Mercè Biosca, Ana Blasco, Rebeca Lozano, Avinash Ramchandani, Carmen Beato, Eva Martínez de Castro, Javier Espinosa, Jerónimo Martínez-García, Ismael Ghanem, Jorge Hernando Cubero, Isabel Aragón Manrique, Francisco García Navalón, Elena Sevillano, Aránzazu Manzano, Juan Virizuela, Marcelo Garrido, Rebeca Mondéjar, María Ángeles Arcusa, Yaiza Bonilla, Quionia Pérez, Elena Gallardo, Maria del Carmen Soriano, Mercè Cardona, Fernando Sánchez Lasheras, Juan Jesús Cruz and Francisco Ayala on behalf of the Supportive Care Working Group of the Spanish Society of Medical Oncology (SEOM) and the FINITE investigators Br J Cancer 2016 114: 1191-1198; advance online publication, May 17, 2016; 10.1038/bjc.2016.118 Abstract | Full Text First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma C Le Tourneau, B Dreno, Y Kirova, J J Grob, T Jouary, C Dutriaux, L Thomas, C Lebbé, L Mortier, P Saiag, M F Avril, E Maubec, P Joly, P Bey, J M Cosset, J S Sun, B Asselain, F Devun, M E Marty and M Dutreix Br J Cancer 2016 114: 1199-1205; advance online publication, May 3, 2016; 10.1038/bjc.2016.120 Abstract | Full Text Translational Therapeutics Top A role for dynamic contrast-enhanced magnetic resonance imaging in predicting tumour radiation response Rami R Hallac, Heling Zhou, Rajesh Pidikiti, Kwang Song, Timothy Solberg, Vikram D Kodibagkar, Peter Peschke and Ralph P Mason Br J Cancer 2016 114: 1206-1211; advance online publication, May 3, 2016; 10.1038/bjc.2016.110 Abstract | Full Text In vivo imaging of eribulin-induced reoxygenation in advanced breast cancer patients: a comparison to bevacizumab Shigeto Ueda, Toshiaki Saeki, Hideki Takeuchi, Takashi Shigekawa, Tomohiko Yamane, Ichiei Kuji and Akihiko Osaki Br J Cancer 2016 114: 1212-1218; advance online publication, May 3, 2016; 10.1038/bjc.2016.122 Abstract | Full Text Inhibition of Bcl-2 family members sensitises soft tissue leiomyosarcomas to chemotherapy Marieke A de Graaff, Marije A J de Rooij, Brendy E W M van den Akker, Hans Gelderblom, Fréderic Chibon, Jean-Michel Coindre, Adrian Marino-Enriquez, Jonathan A Fletcher, Anne-Marie Cleton-Jansen and Judith V M G Bovée Br J Cancer 2016 114: 1219-1226; advance online publication, May 3, 2016; 10.1038/bjc.2016.117 Abstract | Full Text Molecular Diagnostics Top Cancer-associated oxidoreductase ERO1-α drives the production of VEGF via oxidative protein folding and regulating the mRNA level Tsutomu Tanaka, Goro Kutomi, Toshimitsu Kajiwara, Kazuharu Kukita, Vitaly Kochin, Takayuki Kanaseki, Tomohide Tsukahara, Yoshihiko Hirohashi, Toshihiko Torigoe, Yoshiharu Okamoto, Koichi Hirata, Noriyuki Sato and Yasuaki Tamura Br J Cancer 2016 114: 1227-1234; advance online publication, April 21, 2016; 10.1038/bjc.2016.105 Abstract | Full Text Expression of two WFDC1/ps20 isoforms in prostate stromal cells induces paracrine apoptosis through regulation of PTGS2/COX-2 Oliver J Hickman, Richard A Smith, Prokar Dasgupta, Sudha Narayana Rao, Soumya Nayak, Shubha Sreenivasan, Annapurna Vyakarnam and Christine Galustian Br J Cancer 2016 114: 1235-1242; advance online publication, April 26, 2016; 10.1038/bjc.2016.91 Abstract | Full Text Chromatin changes predict recurrence after radical prostatectomy Tarjei S Hveem, Andreas Kleppe, Ljiljana Vlatkovic, Elin Ersvær, Håkon Wæhre, Birgitte Nielsen, Marte Avranden Kjær, Manohar Pradhan, Rolf Anders Syvertsen, John Arne Nesheim, Knut Liestøl, Fritz Albregtsen and Håvard E Danielsen Br J Cancer 2016 114: 1243-1250; advance online publication, April 28, 2016; 10.1038/bjc.2016.96 Abstract | Full Text Full-length LGR5-positive cells have chemoresistant characteristics in colorectal cancer Hideki Osawa, Hidekazu Takahashi, Junichi Nishimura, Katsuya Ohta, Naotsugu Haraguchi, Taishi Hata, Hirofumi Yamamoto, Tsunekazu Mizushima, Ichiro Takemasa, Yuichiro Doki and Masaki Mori Br J Cancer 2016 114: 1251-1260; advance online publication, May 3, 2016; 10.1038/bjc.2016.112 Abstract | Full Text Epidemiology Top Impact of partial bivalent HPV vaccination on vaccine-type infection: a population-based analysis K Cuschieri, K Kavanagh, C Moore, R Bhatia, J Love and K G Pollock Br J Cancer 2016 114: 1261-1264; advance online publication, April 26, 2016; 10.1038/bjc.2016.97 Abstract | Full Text Use of tricyclic antidepressants and risk of glioma: a nationwide case–control study Anton Pottegård, Luis Alberto García Rodríguez, Lotte Rasmussen, Per Damkier, Søren Friis and David Gaist Br J Cancer 2016 114: 1265-1268; advance online publication, April 26, 2016; 10.1038/bjc.2016.109 Abstract | Full Text Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography Gemma Jacklyn, Paul Glasziou, Petra Macaskill and Alexandra Barratt Br J Cancer 2016 114: 1269-1276; advance online publication, April 28, 2016; 10.1038/bjc.2016.90 Abstract | Full Text Association between dietary inflammatory potential and breast cancer incidence and death: results from the Women’s Health Initiative Fred K Tabung, Susan E Steck, Angela D Liese, Jiajia Zhang, Yunsheng Ma, Bette Caan, Rowan T Chlebowski, Jo L Freudenheim, Lifang Hou, Yasmin Mossavar-Rahmani, Nitin Shivappa, Mara Z Vitolins, Jean Wactawski-Wende, Judith K Ockene and James R Hébert Br J Cancer 2016 114: 1277-1285; advance online publication, April 21, 2016; 10.1038/bjc.2016.98 Abstract | Full Text Cost of care for cancer patients in England: evidence from population-based patient-level data Mauro Laudicella, Brendan Walsh, Elaine Burns and Peter C Smith Br J Cancer 2016 114: 1286-1292; advance online publication, April 12, 2016; 10.1038/bjc.2016.77 Abstract | Full Text Health service use and costs in the last 6 months of life in elderly decedents with a history of cancer: a comprehensive analysis from a health payer perspective Julia M Langton, Rebecca Reeve, Preeyaporn Srasuebkul, Marion Haas, Rosalie Viney, David Currow and Sallie-Anne Pearson on behalf of the EOL-CC study authors Br J Cancer 2016 114: 1293-1302; advance online publication, April 26, 2016; 10.1038/bjc.2016.75 Abstract | Full Text Letters to the Editor Top Comment on: ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort’ Caterina Vivaldi, Lorenzo Fornaro, Chiara Caparello, Alfredo Falcone and Enrico Vasile Br J Cancer 2016 114: e8; advance online publication, April 28, 2016; 10.1038/bjc.2016.69 Full Text Reply to the comment on ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort’ Simon Pernot, Jean-Baptiste Bachet, Alix Portal and Julien Taieb Br J Cancer 2016 114: e9; advance online publication, April 28, 2016; 10.1038/bjc.2016.70 Full Text Comment on: ‘Hypertensive diseases in pregnancy and breast cancer risk’ Piera M Cirillo, Christopher C Benz and Barbara A Cohn Br J Cancer 2016 114: e10; advance online publication, May 3, 2016; 10.1038/bjc.2016.81 Full Text Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer’ Ellena Badrick, Matthew Sperrin and Andrew G Renehan Br J Cancer 2016 114: e11; 10.1038/bjc.2016.99 Full Text Reply to ‘Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer’’ Yunxia Lu, Luis Alberto García Rodríguez, Linnéa Malgerud, Antonio González-Pérez, Mar Martín-Pérez, Jesper Lagergren and Tomas S Bexelius Br J Cancer 2016 114: e12; 10.1038/bjc.2016.100 Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.